Amgen
NEULASTA
Manufacturer:
Amgen
Name:
NEULASTA
HCPCS Code Descriptor:
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
Category:
J Code
HCPCS:
J2506
NDC(s):
55513-0190-01, 55513-0192-01
Primary Type:
Oncology Colony Stimulating Factor
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
NEULASTA is an Oncology Colony Stimulating Factor drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2506 is aligned to the drug NEULASTA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/22
HCPCS Effective Date:
4/1/23
HCPCS Short Description:
Inj pegfilgrast ex bio 0.5mg
Billing and Coding Guide:
https://www.amgensupportplus.com/-/media/Themes/Amgen/amgensupportplus-com/Amgensupportplus-com/documents/amgensupportplus/Neulasta-Neupogen-Physician-Billing-and-Coding-Guide.pdf
Patient Assistance:
https://www.amgenassist.com/copay
https://www.amgenassist.com/copay